🇺🇸 FDA
Pipeline program

Elective nodal irradiation (ENI)

2011ESO_FU_02

Phase 3 other active

Quick answer

Elective nodal irradiation (ENI) for Esophageal Squamous Cell Carcinoma is a Phase 3 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Esophageal Squamous Cell Carcinoma
Phase
Phase 3
Modality
other
Status
active

Clinical trials